Evidence map›Paper›PMID 14989223›Full record

GuidelineEuropean journal of nuclear medicine and molecular imaging2003

Breast scintigraphy: procedure guidelines for tumour imaging.

Emilio Bombardieri, Cumali Aktolun, Richard P Baum, Angelika Bishof-Delaloye, John Buscombe, Jean François Chatal, Lorenzo Maffioli, Roy Moncayo, Luc Mortelmans, Sven N Reske

Registry-linked trialAbstract readGuidelinePractice Guideline
PubMed Publisher
In one paragraph

Guideline in European journal of nuclear medicine and molecular imaging, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00804544 (Tc-99m Sestamibi SPECT/CT for Prediction of the Response of Locally Advanced Breast Malignancy to Neoadjuvant Chemotherapy), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00804544 naterminatednot on this mapstarted 2008, after this paper: background citation

Tc-99m Sestamibi SPECT/CT for Prediction of the Response of Locally Advanced Breast Malignancy to Neoadjuvant Chemotherapy

TypeinterventionalSponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sRan2008 to 2010Enrolled4ConditionsBreast CancerArmsSPECT/CT
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Current and future perspectives of molecular breast imaging with [European journal of nuclear medicine and molecular imaging · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emilio BombardieriIstituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy. mednuc@istitutotumori.mi.it
Cumali Aktolun
Richard P Baum
Angelika Bishof-Delaloye
John Buscombe
Jean François Chatal
Lorenzo Maffioli
Roy Moncayo
Luc Mortelmans
Sven N Reske

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Organophosphorus CompoundsOrganotechnetium CompoundsTechnetium Tc 99m SestamibiBreastBreast NeoplasmsEuropeHumansNuclear MedicinePatient Care ManagementPractice Patterns, Physicians'RadiopharmaceuticalsSocieties, MedicalTomography, Emission-ComputedOrganophosphorus CompoundsOrganotechnetium CompoundsRadiopharmaceuticalsTechnetium Tc 99m Sestamibitechnetium tc-99m tetrofosmin

Identifiers

PMID14989223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.